Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy

Glioblastomas (GBM) are the most aggressive tumors originating in the brain. Histopathologic features include circuitous, disorganized, and highly permeable blood vessels with intermittent blood flow. These features contribute to the inability to direct therapeutic agents to tumor cells. Known targe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Cinzia Cocola, Valerio Magnaghi, Edoardo Abeni, Paride Pelucchi, Valentina Martino, Laura Vilardo, Eleonora Piscitelli, Arianna Consiglio, Giorgio Grillo, Ettore Mosca, Roberta Gualtierotti, Daniela Mazzaccaro, Gina La Sala, Chiara Di Pietro, Mira Palizban, Sabino Liuni, Giuseppina DePedro, Stefano Morara, Giovanni Nano, James Kehler, Burkhard Greve, Alessio Noghero, Daniela Marazziti, Federico Bussolino, Gianfranco Bellipanni, Igea D’Agnano, Martin Götte, Ileana Zucchi, Rolland Reinbold
Format:	article
Language:	EN
Published:	Frontiers Media S.A. 2021
Subjects:	cargo vesicle transport angiogenesis and normalization of vascular network tumor cell migration and adhesion anticancer and antiangiogenic therapy glioma kinesin motor proteins Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Online Access:	https://doaj.org/article/75f0ce9fbf4943ef8b3abd80f17950d9
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy

Similar Items